Press release
Axial Spondyloarthritis (axSpA) Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Novartis, Pfizer, Merck, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lil
To Know in detail about the Axial Spondyloarthritis (axSpA) market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Axial Spondyloarthritis (axSpA) Market Forecast
https://www.delveinsight.com/sample-request/axial-spondyloarthritis-axspa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Axial Spondyloarthritis (axSpA) Market Report:
• The Axial Spondyloarthritis (axSpA) market size was valued approximately USD 5,590 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• A total of 3,981,346 individuals in the 7MM were overall prevalent for axSpA. Throughout the prediction period (from 2022 to 2032), it is expected that these cases will rise
• The US reported the highest number of axSpA cases in 2021, totaling 2,217,315 instances, while the EU5 countries reported 1,751,778 cases during the same period
• Japan had the fewest diagnosed prevalent instances of axSpA (7MM) in 2021 with 5,000 cases
• Due to its benign history, ankylosing spondylitis is almost never detected in the US in about 50% of patients. In the US, the time between the development of symptoms and the diagnosis of ankylosing spondylitis has been estimated to be around 13 years
• Key Axial Spondyloarthritis (axSpA) Companies: UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, and others
• Key Axial Spondyloarthritis (axSpA) Therapies: Bimekizumab, CC-99677, ABY- 035, Filgotinib, KHK4827, Ixekizumab, Golimumab, etanercept, Secukinumab, SHR0302, Certolizumab Pegol, and others
• The Axial Spondyloarthritis (axSpA) epidemiology based on gender analyzed that the prevalent population of Axial Spondyloarthritis showed a male predominance, whereas, nr-axSpA showed female predominance.
• The Axial Spondyloarthritis (axSpA) market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Axial Spondyloarthritis (axSpA) pipeline products will significantly revolutionize the Axial Spondyloarthritis (axSpA) market dynamics.
Axial Spondyloarthritis (axSpA) Overview
Ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) are two subtypes of the chronic, immune-mediated, inflammatory illness known as axial spondyloarthritis (axSpA).
Get a Free sample for the Axial Spondyloarthritis (axSpA) Market Report
https://www.delveinsight.com/report-store/axial-spondyloarthritis-axspa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Axial Spondyloarthritis (axSpA) Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Axial Spondyloarthritis (axSpA) Epidemiology Segmentation:
The Axial Spondyloarthritis (axSpA) market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Axial Spondyloarthritis (axSpA)
• Prevalent Cases of Axial Spondyloarthritis (axSpA) by severity
• Gender-specific Prevalence of Axial Spondyloarthritis (axSpA)
• Diagnosed Cases of Episodic and Chronic Axial Spondyloarthritis (axSpA)
Download the report to understand which factors are driving Axial Spondyloarthritis (axSpA) epidemiology trends @ Axial Spondyloarthritis (axSpA) Epidemiology Forecast
https://www.delveinsight.com/sample-request/axial-spondyloarthritis-axspa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Axial Spondyloarthritis (axSpA) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Axial Spondyloarthritis (axSpA) market or expected to get launched during the study period. The analysis covers Axial Spondyloarthritis (axSpA) market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Axial Spondyloarthritis (axSpA) Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Axial Spondyloarthritis (axSpA) Therapies and Key Companies
• Bimekizumab: UCB Biopharma
• CC-99677: Celgene
• ABY- 035: Inmagene Biopharmaceuticals
• Filgotinib: Galapagos NV
• KHK4827: Kyowa Kirin Co., Ltd.
• Ixekizumab: Eli Lilly and Company
• Golimumab: Merck Sharp & Dohme LLC
• etanercept: Pfizer
• Bimekizumab: UCB Biopharma
• Secukinumab: Novartis
• SHR0302: Jiangsu HengRui Medicine
• Certolizumab Pegol: UCB Biopharma
Discover more about therapies set to grab major Axial Spondyloarthritis (axSpA) market share @ Axial Spondyloarthritis (axSpA) Treatment Market
https://www.delveinsight.com/sample-request/axial-spondyloarthritis-axspa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Axial Spondyloarthritis (axSpA) Market Drivers
• The introduction of novel products
• Increasing prevalence
• Awareness about the Disease
• Research and development strategies
Axial Spondyloarthritis (axSpA) Market Barriers
• High-cost treatment
• Delay in Diagnosis
• Immunogenicity
• Loss of patent exclusivity
• Availability of generics
• Poor Quality of Life
Scope of the Axial Spondyloarthritis (axSpA) Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Axial Spondyloarthritis (axSpA) Companies: UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, and others
• Key Axial Spondyloarthritis (axSpA) Therapies: Bimekizumab, CC-99677, ABY- 035, Filgotinib, KHK4827, Ixekizumab, Golimumab, etanercept, Secukinumab, SHR0302, Certolizumab Pegol, and others
• Axial Spondyloarthritis (axSpA) Therapeutic Assessment: Axial Spondyloarthritis (axSpA) current marketed and Axial Spondyloarthritis (axSpA) emerging therapies
• Axial Spondyloarthritis (axSpA) Market Dynamics: Axial Spondyloarthritis (axSpA) market drivers and Axial Spondyloarthritis (axSpA) market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Axial Spondyloarthritis (axSpA) Unmet Needs, KOL's views, Analyst's views, Axial Spondyloarthritis (axSpA) Market Access and Reimbursement
To know more about Axial Spondyloarthritis (axSpA) companies working in the treatment market, visit @ Axial Spondyloarthritis (axSpA) Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/axial-spondyloarthritis-axspa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Axial Spondyloarthritis (axSpA) Market Report Introduction
2. Executive Summary for Axial Spondyloarthritis (axSpA)
3. SWOT analysis of Axial Spondyloarthritis (axSpA)
4. Axial Spondyloarthritis (axSpA) Patient Share (%) Overview at a Glance
5. Axial Spondyloarthritis (axSpA) Market Overview at a Glance
6. Axial Spondyloarthritis (axSpA) Disease Background and Overview
7. Axial Spondyloarthritis (axSpA) Epidemiology and Patient Population
8. Country-Specific Patient Population of Axial Spondyloarthritis (axSpA)
9. Axial Spondyloarthritis (axSpA) Current Treatment and Medical Practices
10. Axial Spondyloarthritis (axSpA) Unmet Needs
11. Axial Spondyloarthritis (axSpA) Emerging Therapies
12. Axial Spondyloarthritis (axSpA) Market Outlook
13. Country-Wise Axial Spondyloarthritis (axSpA) Market Analysis (2019-2032)
14. Axial Spondyloarthritis (axSpA) Market Access and Reimbursement of Therapies
15. Axial Spondyloarthritis (axSpA) Market Drivers
16. Axial Spondyloarthritis (axSpA) Market Barriers
17. Axial Spondyloarthritis (axSpA) Appendix
18. Axial Spondyloarthritis (axSpA) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Axial Spondyloarthritis (axSpA) Pipeline https://www.delveinsight.com/report-store/axial-spondyloarthritis-axspa-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Axial Spondyloarthritis (axSpA) Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Axial Spondyloarthritis (axSpA) market. A detailed picture of the Axial Spondyloarthritis (axSpA) pipeline landscape is provided, which includes the disease overview and Axial Spondyloarthritis (axSpA) treatment guidelines.
Axial Spondyloarthritis (axSpA) Epidemiology
https://www.delveinsight.com/report-store/axial-spondyloarthritis-axspa-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Axial Spondyloarthritis (axSpA) Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Axial Spondyloarthritis (axSpA) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Huntington's Disease Market
https://www.delveinsight.com/report-store/huntingtons-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Huntington's Disease Epidemiology
https://www.delveinsight.com/report-store/huntingtons-disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Huntington's Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axial Spondyloarthritis (axSpA) Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Novartis, Pfizer, Merck, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lil here
News-ID: 3245340 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Axial
Transformative Trends Impacting the Axial Lead Capacitors Market Landscape: Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Axial Lead Capacitors Market Size By 2025?
The market size for axial lead capacitors has seen robust growth in the past years. The market is projected to increase from $0.98 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR)…
Six Axial Simulation Table Market Size Analysis by Application, Type, and Region …
According to Market Research Intellect, the global Six Axial Simulation Table market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The six axial simulation table market is experiencing notable growth due to its expanding use in…
Axial Flow Pump Market Fueled By Growing Freshwater Needs: An Emerging Driver Tr …
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Axial Flow Pump Market?
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Axial Spondyloarthritis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Axial Spondyloarthritis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Axial Spondyloarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Axial Spondyloarthritis Research. Learn more about…
Axial Flow Pump Market Reaches $44B by 2031
Axial Flow Pump Market Scope:
Key Insights : Axial Flow Pump Market size was valued at USD 29.83 billion in 2022 and is poised to grow from USD 31.14 billion in 2023 to USD 43.95 billion by 2031, growing at a CAGR of 4.4% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/axial-flow-pump-market
In-Depth Exploration of the global Axial Flow Pump Market: This report…
Axial Extensometers Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Axial Extensometers Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Axial Extensometers players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Axial Extensometers with respect to individual growth…
